M. Y. Neufeld, F. Mawassi, A. Levy, T. A. Treves, A. D. Korczyn, "Transdermal Physostigmine—Absence of Effect on Topographic Brain Mapping", Behavioural Neurology, vol. 6, Article ID 892685, 3 pages, 1993. https://doi.org/10.3233/BEN-1993-6105
Transdermal Physostigmine—Absence of Effect on Topographic Brain Mapping
Nine patients with primary degenerative dementia (PDD) participated in an open trial of transdermal physostigmine (TPh). In order to evaluate the neurophysiologic effects of TPh, EEG data were recorded and compared at baseline and following 2 months of continuous treatment. There was no significant effect of TPh on EEG spectra in patients with PDD.
Copyright © 1993 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.